上海莼試生物技術(shù)有限公司
主營產(chǎn)品: ELISA試劑盒,ELISA試劑盒價(jià)格,ELISA試劑盒報(bào)價(jià) |
聯(lián)系電話
13585831301
公司信息
- 聯(lián)系人:
- 李小姐
- 電話:
- 021-59541103
- 手機(jī):
- 13585831301
- 售后電話:
- 13585831301
- 傳真:
- 021-60443211
- 地址:
- 上海市嘉定區(qū)嘉羅公路1661號(hào)
- 郵編:
參考價(jià) | 面議 |
- 型號(hào)
- 品牌
- 廠商性質(zhì) 經(jīng)銷商
- 所在地 上海市
更新時(shí)間:2021-12-28 17:07:42瀏覽次數(shù):513
聯(lián)系我們時(shí)請說明是環(huán)保在線上看到的信息,謝謝!
公司提供的*554-13-2售后服務(wù)保證,貨源充足。嚴(yán)格的質(zhì)量控制體系,包括:優(yōu)級純,分析純,化學(xué)純,試劑級,基準(zhǔn)試劑,實(shí)驗(yàn)純,教學(xué)試劑,高純試劑,色譜純,光譜純,電子純。各種包裝規(guī)格,并可提供包裝定制,咨詢訂購。
*554-13-2售后服務(wù)英文名稱: Lithium Carbonate
其他英文名稱: Carbolith;Carbolithium;Lithonate
產(chǎn)品規(guī)格: 4N
包裝:50克
產(chǎn)品規(guī)格: AR
包裝:250克/500克
:554-13-2
Li2CO3=73.89
級別:4N
級別:AR
含量:≥98.0%
氯化物:≤0.005%
硫酸鹽:≤0.05%
硝酸鹽:≤0.003%
磷酸鹽:≤0.002%
鹽酸不溶物:≤0.01%
重金屬(以Pb計(jì)):≤0.002%
鐵:≤0.002%
鈉:≤0.05%
鎂:≤0.01%
鈣:≤0.03%
鉀:≤0.05%
澄清度試驗(yàn):≤5號(hào)
性狀:粉末。輕質(zhì)。有堿性。1G溶于78ml冷水和140ml沸水,溶于稀酸,幾乎不溶于乙醇。相對密度2.11。熔點(diǎn)618℃。沸點(diǎn)735℃。低毒,半數(shù)致死量(大鼠,經(jīng)口)0.71G/kG。有刺激性。
用途:生化研究。鋰鹽。陶瓷、玻璃工業(yè)
保存:RT
產(chǎn)品名稱 | |
英文名稱 | Lithium Carbonate |
發(fā)貨 | 上海 |
特點(diǎn):
1.現(xiàn)貨直銷,當(dāng)天下單,當(dāng)天發(fā)貨。
2.產(chǎn)品優(yōu)質(zhì),到貨快,免費(fèi)快遞。
3.售前、售中、售后服務(wù)好。
有全、新、優(yōu)、品、好五大特點(diǎn):
全:公司提供上萬種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
品:公司代理sigma,amresco,oxoid,wako,R&D,RB,MBL,TCI,GIBIO,等國內(nèi)外。
好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。
我們提供試劑品牌有Merck、Spectrum、BioAssay Systems、Jaica、Scharlab、Sigma-Aldrich、Amresco、Amersham等試劑品牌,試劑純度高、規(guī)格多、包裝好,規(guī)格包括:優(yōu)級純,分析純,化學(xué)純,試劑級,基準(zhǔn)試劑,實(shí)驗(yàn)純,教學(xué)試劑,高純試劑,色譜純,光譜純,電子純。
DL- 兒茶素03295-100
D/L-* 851
D/L-阿拉伯糖
CENTAUREIN
CENTAUREIDINE
CAULOPHYLLOGENIN(SH033255
CATHARANTHINE(RG03326
CATENARIN(RG033205
CATALPOL(RG032755
B-柏木烯03333-100
BZn15-20鋅白銅光譜分析標(biāo)準(zhǔn)物質(zhì)(G02105-G02109
BZn15-20鋅白銅 光譜標(biāo)樣(BYG1989-4-1-BYG1989-4-4,8,75
BMn40-1.5錳白銅 光譜標(biāo)樣(BYG19861-BYG19865
BETA-羥基乙基*;乙羥*(E2500000
B19白銅 光譜標(biāo)樣(BYG19841-BYG19846
a-鵝膏蕈堿或蠅蕈素020055
a-鵝膏蕈堿或蠅蕈素02005
a-鵝膏蕈堿或蠅蕈素016451
a-鵝膏蕈堿或蠅蕈素01645
ASPIDOSINE HYDROBROMIDE(RG016875
ARICINE(RG 950
ARGININE, L-(RG 805
1-β-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
2-Ami,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; Aciclovir
2-Ami,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; Aciclovir
L-Valine 2-(2-Ami,6-dihydro-6-oxo-9H-purin-9-ylmethoxy)ethyl Ester Hydrochloride hydrate; valaciclovir
L-Valine 2-(2-Ami,6-dihydro-6-oxo-9H-purin-9-ylmethoxy)ethyl Ester Hydrochloride hydrate; valaciclovir
Suberohydroxamic acid; suberic bis-hydroxamic acid; N,N’-dihydroxyoctanediamide
Suberohydroxamic acid; suberic bis-hydroxamic acid; N,N’-dihydroxyoctanediamide
2-
2-
4,5,6,7-Tetrachloro-1H-indene-1,3(2H)-dione
4,5,6,7-Tetrachloro-1H-indene-1,3(2H)-dione
(2R)-2-[[6-[(3-Amino-5-chlorophenyl)amino]-9-(1-methylethyl)-9H-purin-2-yl]amino]-3-methyl-1-butanol; NG97
(2R)-2-[[6-[(3-Amino-5-chlorophenyl)amino]-9-(1-methylethyl)-9H-purin-2-yl]amino]-3-methyl-1-butanol; NG97
MeOSuc-Ala-Ala-Pro-Met-pNA
MeOSuc-Ala-Ala-Pro-Met-pNA
Boc- Lys(Ac)-pNA
Boc- Lys(Ac)-pNA
3,5-Bis(4-nitrophenoxy)benzoic acid; CW
3,5-Bis(4-nitrophenoxy)benzoic acid; CW
(4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)- 3,5,10,12,12a-pentahydroxy- 6-methyl- 1,11-dioxo- 1,4,4a,5,5a,6,11,12a-octahydrotetracene- 2-carboxamide hydrochloride
(4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)- 3,5,10,12,12a-pentahydroxy- 6-methyl- 1,11-dioxo- 1,4,4a,5,5a,6,11,12a-octahydrotetracene- 2-carboxamide hydrochloride
3-[(2S,4S,5R)-5,6-Dichloro-2,4-dimethyl-1-oxohexyl]-4-hydroxy-5,6-dimethoxy-2(1H)-pyridinone
3-[(2S,4S,5R)-5,6-Dichloro-2,4-dimethyl-1-oxohexyl]-4-hydroxy-5,6-dimethoxy-2(1H)-pyridinone
5E/Z)-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione
4-(2-Amino-4-oxo-2-imidazolidin-5-ylidene)-2-bromo-4,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one; Hymenialdisine
4-(2-Amino-4-oxo-2-imidazolidin-5-ylidene)-2-bromo-4,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one; Hymenialdisine
10-Demethoxy-10-methylthiocolchicine; NSC 186301
10-Demethoxy-10-methylthiocolchicine; NSC 186301
Terpendole C
Terpendole C
Koningic acid; Avocettin; FO-4443; BRN 5091359
Koningic acid; Avocettin; FO-4443; BRN 5091359
N-(2-Methoxy-2-oxoacetyl)glycine methyl ester
N-(2-Methoxy-2-oxoacetyl)glycine methyl ester
2-[(1-Methylpropyl)dithio]-1H-imidazole; IV-2
2-[(1-Methylpropyl)dithio]-1H-imidazole; IV-2
ATRA; Tretinoin; NSC 122758; Vitamin A Acid; all-trans Retinoic Acid; NSC 122578
ATRA; Tretinoin; NSC 122758; Vitamin A Acid; all-trans Retinoic Acid; NSC 122578
1-Thio-β-D-glucopyranosatotriethylphosphine gold-2,3,4,6-tetraacetate; SKF39162
1-Thio-β-D-glucopyranosatotriethylphosphine gold-2,3,4,6-tetraacetate; SKF39162
GSK1210151A
GSK1210151A
Volasertib
Volasertib
PaTrin-2; 6-
PaTrin-2; 6-
1H-
1H-
3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide; NSC 362856; CCRG 81045
3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide; NSC 362856; CCRG 81045
(2E)-1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-propenone hydrochloride
(2E)-1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-propenone hydrochloride
[5-(1,1-Dioxo-thiomorpholin-4-ylmethyl)-2-phenyl-1H-indol-7-yl]-(1-methanesulfonyl-piperidin-4-yl)-amine
[5-(1,1-Dioxo-thiomorpholin-4-ylmethyl)-2-phenyl-1H-indol-7-yl]-(1-methanesulfonyl-piperidin-4-yl)-amine
[5-(1,1-Dioxo-thiomorpholin-4-ylmethyl)-2-phenyl-1H-indol-7-yl]-(tetrahydro-pyran-4-ylmethyl)-amine, dihydrochloride
[5-(1,1-Dioxo-thiomorpholin-4-ylmethyl)-2-phenyl-1H-indol-7-yl]-(tetrahydro-pyran-4-ylmethyl)-amine, dihydrochloride
Fer-1; Ethyl 3-amino-4-(cyclohexylamino)benzoate
Fer-1; Ethyl 3-amino-4-(cyclohexylamino)benzoate
Taxotere; Docefrez
Taxotere; Docefrez
6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide; Selumetinib; ARRY-142886
6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide; Selumetinib; ARRY-142886
Vemurafenib; RG7204, RO5185426
Vemurafenib; RG7204, RO5185426
(2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
(2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
(1R)-2,3-Dihydro-N-2-propynyl-1H-inden-1-amine methanesulfonate
(1R)-2,3-Dihydro-N-2-propynyl-1H-inden-1-amine methanesulfonate
Cyclo(D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl)
Cyclo(D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl)
2-Methoxy-5-[(1Z)-2-(3,4,5-trimetho-xyphenyl)ethenyl]phenol; CRC 87-09, NSC 817373
2-Methoxy-5-[(1Z)-2-(3,4,5-trimetho-xyphenyl)ethenyl]phenol; CRC 87-09, NSC 817373